HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,647 shares of the company's stock after selling 6,325 shares during the period. O Shaughnessy Asset Management LLC's holdings in HCA Healthcare were worth $12,800,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE raised its stake in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the period. Evergreen Private Wealth LLC raised its stake in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after acquiring an additional 35 shares during the period. Mediolanum International Funds Ltd boosted its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after buying an additional 36 shares during the period. Prairie Wealth Advisors Inc. raised its position in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after buying an additional 40 shares in the last quarter. Finally, Whittier Trust Co. increased its stake in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Remove Ads

HCA Healthcare Stock Up 0.5 %

Shares of HCA stock traded up $1.75 on Wednesday, hitting $347.48. The stock had a trading volume of 1,249,318 shares, compared to its average volume of 1,349,682. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The business has a 50 day moving average price of $326.35 and a 200 day moving average price of $340.30. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market cap of $85.55 billion, a PE ratio of 15.82, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company earned $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is currently 13.11%.

Analysts Set New Price Targets

Several brokerages recently issued reports on HCA. Royal Bank of Canada lowered their target price on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. Barclays decreased their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.